ROIV
Roivant Sciences Ltd

1,940
Loading...
Loading...
Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. The company was founded by Vivek Ramaswamy on April 7, 2014 and is headquartered in London, the United Kingdom.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
750

Frequently Asked Questions

What is Market Cap of Roivant Sciences Ltd?
What is the 52-week high for Roivant Sciences Ltd?
What is the 52-week low for Roivant Sciences Ltd?
What is Roivant Sciences Ltd stock price today?
What was Roivant Sciences Ltd stock price yesterday?
What is the PE ratio of Roivant Sciences Ltd?
What is the Price-to-Book ratio of Roivant Sciences Ltd?
What is the 50-day moving average of Roivant Sciences Ltd?
How many employess does Roivant Sciences Ltd has?

Latest ROIV News

View

Advertisement|Remove ads.

Advertisement|Remove ads.